Safety, Efficacy, and Pharmacokinetic Study of Intravenous Ibuprofen in Pediatric Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Fever
Interventions
DRUG

ibuprofen

Ibuprofen, 10 mg/kg

DRUG

acetaminophen

Acetaminophen, 10mg/kg

Trial Locations (17)

10305

Staten Island University Hospital, Staten Island

20060

Howard University, Washington D.C.

30909

Joseph M. Still Burn Center, Augusta

32804

Florida Hospital, Orlando

33136

Jackson Memorial Hospital (U. Miami), Miami

38103

LeBonheur Children's Hospital, Memphis

40202

Kosair Children's Hospital, Louisville

48201

Children's Hospital of Michigan, Detroit

71103

LSU Health Sciences Center, Shreveport

74136

The Children's Hospital at Saint Francis, Tulsa

75235

Children's Medical Center Dallas, Dallas

77030

Children's Memorial Hermann Hospital, Houston

Texas Children's Hospital, Houston

85008

Maricopa Medical Center, Phoenix

92354

Loma Linda University Medical Center, Loma Linda

92868

Children's Hospital of Orange County, Orange

70121-2483

Ochsner Clinic Foundation, New Orleans

Sponsors
All Listed Sponsors
lead

Cumberland Pharmaceuticals

INDUSTRY

NCT01002573 - Safety, Efficacy, and Pharmacokinetic Study of Intravenous Ibuprofen in Pediatric Patients | Biotech Hunter | Biotech Hunter